Logo image of BRLT

BRILLIANT EARTH GROUP INC-A (BRLT) Stock Fundamental Analysis

NASDAQ:BRLT - Nasdaq - US1095041000 - Common Stock - Currency: USD

1.5  0 (0%)

After market: 1.53 +0.03 (+2%)

Fundamental Rating

4

BRLT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 123 industry peers in the Specialty Retail industry. BRLT has an average financial health and profitability rating. BRLT has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BRLT was profitable.
In the past year BRLT had a positive cash flow from operations.
BRLT had positive earnings in each of the past 5 years.
Each year in the past 5 years BRLT had a positive operating cash flow.
BRLT Yearly Net Income VS EBIT VS OCF VS FCFBRLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

BRLT has a Return On Assets of -0.02%. This is comparable to the rest of the industry: BRLT outperforms 47.54% of its industry peers.
The Return On Equity of BRLT (-0.43%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.02%
ROE -0.43%
ROIC N/A
ROA(3y)0.4%
ROA(5y)5.45%
ROE(3y)9.15%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BRLT Yearly ROA, ROE, ROICBRLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

BRLT's Profit Margin has declined in the last couple of years.
BRLT's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 59.98%, BRLT belongs to the top of the industry, outperforming 86.89% of the companies in the same industry.
BRLT's Gross Margin has improved in the last couple of years.
BRLT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.98%
OM growth 3Y-57.78%
OM growth 5YN/A
PM growth 3Y-31.26%
PM growth 5YN/A
GM growth 3Y6.93%
GM growth 5Y7.4%
BRLT Yearly Profit, Operating, Gross MarginsBRLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60

5

2. Health

2.1 Basic Checks

BRLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BRLT has been increased compared to 1 year ago.
The number of shares outstanding for BRLT has been increased compared to 5 years ago.
BRLT has a better debt/assets ratio than last year.
BRLT Yearly Shares OutstandingBRLT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BRLT Yearly Total Debt VS Total AssetsBRLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 2.41 indicates that BRLT is not a great score, but indicates only limited risk for bankruptcy at the moment.
BRLT has a Altman-Z score (2.41) which is comparable to the rest of the industry.
The Debt to FCF ratio of BRLT is 4.87, which is a neutral value as it means it would take BRLT, 4.87 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.87, BRLT is in the better half of the industry, outperforming 67.21% of the companies in the same industry.
BRLT has a Debt/Equity ratio of 2.31. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.31, BRLT is not doing good in the industry: 71.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.31
Debt/FCF 4.87
Altman-Z 2.41
ROIC/WACCN/A
WACC8.39%
BRLT Yearly LT Debt VS Equity VS FCFBRLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.27 indicates that BRLT has no problem at all paying its short term obligations.
BRLT has a Current ratio of 2.27. This is amongst the best in the industry. BRLT outperforms 85.25% of its industry peers.
BRLT has a Quick Ratio of 1.81. This is a normal value and indicates that BRLT is financially healthy and should not expect problems in meeting its short term obligations.
BRLT's Quick ratio of 1.81 is amongst the best of the industry. BRLT outperforms 87.70% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.81
BRLT Yearly Current Assets VS Current LiabilitesBRLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2

3. Growth

3.1 Past

The earnings per share for BRLT have decreased strongly by -43.75% in the last year.
Looking at the last year, BRLT shows a decrease in Revenue. The Revenue has decreased by -6.14% in the last year.
The Revenue has been growing by 15.96% on average over the past years. This is quite good.
EPS 1Y (TTM)-43.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y3.55%
Revenue growth 5Y15.96%
Sales Q2Q%-3.55%

3.2 Future

BRLT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -28.59% yearly.
BRLT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.12% yearly.
EPS Next Y-54.1%
EPS Next 2Y-28.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.39%
Revenue Next 2Y3.12%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRLT Yearly Revenue VS EstimatesBRLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
BRLT Yearly EPS VS EstimatesBRLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

4

4. Valuation

4.1 Price/Earnings Ratio

BRLT is valuated correctly with a Price/Earnings ratio of 16.67.
Based on the Price/Earnings ratio, BRLT is valued a bit cheaper than 74.59% of the companies in the same industry.
BRLT is valuated rather cheaply when we compare the Price/Earnings ratio to 26.82, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 24.51, BRLT is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as BRLT.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.21, BRLT is valued a bit cheaper.
Industry RankSector Rank
PE 16.67
Fwd PE 24.51
BRLT Price Earnings VS Forward Price EarningsBRLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

BRLT's Enterprise Value to EBITDA is on the same level as the industry average.
BRLT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BRLT is cheaper than 76.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.32
EV/EBITDA 12.35
BRLT Per share dataBRLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

BRLT's earnings are expected to decrease with -28.59% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-28.59%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BRLT!.
Industry RankSector Rank
Dividend Yield N/A

BRILLIANT EARTH GROUP INC-A

NASDAQ:BRLT (8/1/2025, 8:24:03 PM)

After market: 1.53 +0.03 (+2%)

1.5

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners29.35%
Inst Owner Change0.05%
Ins Owners5.97%
Ins Owner Change1.08%
Market Cap148.97M
Analysts73.33
Price Target2.17 (44.67%)
Short Float %0.4%
Short Ratio0.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)426.8%
Min EPS beat(2)100%
Max EPS beat(2)753.6%
EPS beat(4)4
Avg EPS beat(4)605.56%
Min EPS beat(4)100%
Max EPS beat(4)1080.39%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)0.29%
Revenue beat(4)1
Avg Revenue beat(4)-2.01%
Min Revenue beat(4)-3.54%
Max Revenue beat(4)0.29%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.4%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-260%
EPS NY rev (1m)0%
EPS NY rev (3m)3.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.07%
Valuation
Industry RankSector Rank
PE 16.67
Fwd PE 24.51
P/S 0.36
P/FCF 13.32
P/OCF 9.16
P/B 9.98
P/tB 9.98
EV/EBITDA 12.35
EPS(TTM)0.09
EY6%
EPS(NY)0.06
Fwd EY4.08%
FCF(TTM)0.11
FCFY7.51%
OCF(TTM)0.16
OCFY10.91%
SpS4.22
BVpS0.15
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.02%
ROE -0.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.98%
FCFM 2.67%
ROA(3y)0.4%
ROA(5y)5.45%
ROE(3y)9.15%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.44%
ROCE(5y)21.13%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-57.78%
OM growth 5YN/A
PM growth 3Y-31.26%
PM growth 5YN/A
GM growth 3Y6.93%
GM growth 5Y7.4%
F-Score5
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 2.31
Debt/FCF 4.87
Debt/EBITDA 7.59
Cap/Depr 90.62%
Cap/Sales 1.21%
Interest Coverage N/A
Cash Conversion 357.55%
Profit Quality N/A
Current Ratio 2.27
Quick Ratio 1.81
Altman-Z 2.41
F-Score5
WACC8.39%
ROIC/WACCN/A
Cap/Depr(3y)283.92%
Cap/Depr(5y)318.66%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.52%
Profit Quality(3y)1681.82%
Profit Quality(5y)1572.89%
High Growth Momentum
Growth
EPS 1Y (TTM)-43.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-54.1%
EPS Next 2Y-28.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y3.55%
Revenue growth 5Y15.96%
Sales Q2Q%-3.55%
Revenue Next Year2.39%
Revenue Next 2Y3.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-119.18%
EBIT growth 3Y-56.28%
EBIT growth 5YN/A
EBIT Next Year131.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y11086%
FCF growth 3Y-32.07%
FCF growth 5YN/A
OCF growth 1Y31.64%
OCF growth 3Y-27.45%
OCF growth 5Y98.57%